Status:
COMPLETED
Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma
Lead Sponsor:
University of Aberdeen
Collaborating Sponsors:
Cancer Research UK
Conditions:
Melanoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The ASICA study is looking at how the UK National Health Service (NHS) might use technology in the future to more effectively support people who have been treated for melanoma.
Detailed Description
All patients who have been treated for melanoma are advised to regularly examine their own skin (total-skin-self-examinations; TSSE) but research has found that many people are not shown how to do thi...
Eligibility Criteria
Inclusion
- Adult (≥18)
- Patients treated for stage 0-2C cutaneous melanoma within the preceding 24 months
Exclusion
- Stage 3 and 4 melanoma.
- Previous local recurrence of melanoma within last 24 months.
- Patients who are unable to consent and/or complete questionnaires (e.g. due to cognitive or language issues).
- Patients who are blind or visually impaired.
Key Trial Info
Start Date :
January 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT03328247
Start Date
January 12 2018
End Date
March 31 2020
Last Update
April 28 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Aberdeen
Aberdeen, United Kingdom
2
Addenbrookes Hospital
Cambridge, United Kingdom